The potential role of interferon‐mediated CD4 T cell activation in patients with CLS was supported by midcycle increases in activated, non‐proliferating HLA‐DR+ and CD38+ CD4 T‐cells, along with non‐proliferating TIM3+ CD4 T cells. The gene discussed is HAVCR2; the disease is capillary leak syndrome.